Predicting Mortality for Patients Eligible for Extracorporeal Membrane Oxygenation for COVID-19
Am J Respir Crit Care Med
.
2022 Sep 1;206(5):628-632.
doi: 10.1164/rccm.202202-0237LE.
Authors
Whitney D Gannon
1
,
John W Stokes
1
,
Wu Gong
1
,
Christopher J Lindsell
1
,
Joseph E Tonna
2
,
Matthew Bacchetta
1
,
Todd W Rice
1
,
Matthew W Semler
1
,
Jonathan D Casey
1
Affiliations
1
Vanderbilt University Medical Center Nashville, Tennessee.
2
University of Utah Health Salt Lake City, Utah.
PMID:
35549663
PMCID:
PMC9716900
DOI:
10.1164/rccm.202202-0237LE
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
MeSH terms
COVID-19*
Extracorporeal Membrane Oxygenation*
Hospital Mortality
Humans
Respiration, Artificial
Respiratory Distress Syndrome*
Retrospective Studies
Grants and funding
K23HL153584/HB/NHLBI NIH HHS/United States
K23HL143053/HB/NHLBI NIH HHS/United States